Induction of positive cellular and humoral immune responses by a prime-boost vaccine encoded with simian immunodeficiency virus gag/pol

被引:15
|
作者
Someya, K
Ami, Y
Nakasone, T
Izumi, Y
Matsuo, K
Horibata, S
Xin, KQ
Yamamoto, H
Okuda, K
Yamamoto, N
Honda, M
机构
[1] Natl Inst Infect Dis, AIDS Res Ctr, Shinjuku Ku, Tokyo 1628640, Japan
[2] Natl Inst Infect Dis, Div Expt Anim Res, Shinjuku Ku, Tokyo 1628640, Japan
[3] Yokohama City Univ, Sch Med, Dept Bacteriol, Yokohama, Kanagawa 232, Japan
[4] Toyama Med & Pharmaceut Univ, Lab Anim Res Ctr, Toyama, Japan
来源
JOURNAL OF IMMUNOLOGY | 2006年 / 176卷 / 03期
关键词
D O I
10.4049/jimmunol.176.3.1784
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
It is believed likely that immune responses are responsible for controlling viral load and infection. In this study, when macaques were primed with plasmid DNA encoding SIV gag and pol genes (SIV gag/pol DNA) and then boosted with replication-deficient vaccinia virus DIs recombinant expressing the same genes (rDIsSIV gag/pol), this prime-boost regimen generated higher levels of Gag-specific CD4(+) and CD8(+) T cell responses than did either SIVgag/pol DNA or rDIsSIV gag/pol alone. When the macaques were i.v. challenged with pathogenic simian/HIV, the prime-boost group maintained high CD4(+) T cell counts and reduced plasma viral loads up to 30 wk after viral challenge, whereas the rDIsSIV gag/pol group showed only a partial attenuation of the viral infection, and the group immunized with SIV gag/pol DNA alone showed none at all. The protection levels were better correlated with the levels of virus-specific T cell responses than the levels of neutralization Ab responses. These results demonstrate that a vaccine regimen that primes with DNA and then boosts with a replication-defective vaccinia virus DIs generates anti-SIV immunity, suggesting that it will be a promising vaccine regimen for HIV-1 vaccine development.
引用
收藏
页码:1784 / 1795
页数:12
相关论文
共 50 条
  • [1] DNA Prime-Boost Vaccine Regimen To Increase Breadth, Magnitude, and Cytotoxicity of the Cellular Immune Responses to Subdominant Gag Epitopes of Simian Immunodeficiency Virus and HIV
    Hu, Xintao
    Valentin, Antonio
    Dayton, Frances
    Kulkarni, Viraj
    Alicea, Candido
    Rosati, Margherita
    Chowdhury, Bhabadeb
    Gautam, Rajeev
    Broderick, Kate E.
    Sardesai, Niranjan Y.
    Martin, Malcolm A.
    Mullins, James I.
    Pavlakis, George N.
    Felber, Barbara K.
    [J]. JOURNAL OF IMMUNOLOGY, 2016, 197 (10): : 3999 - 4013
  • [2] Acute effects of pathogenic simian-human immunodeficiency virus challenge on vaccine-induced cellular and humoral immune responses to Gag in rhesus macaques
    Steger, KK
    Waterman, PM
    Pauza, CD
    [J]. JOURNAL OF VIROLOGY, 1999, 73 (03) : 1853 - 1859
  • [3] Induction of cellular immune responses to simian immunodeficiency virus gag by two recombinant negative-strand RNA virus vectors
    Nakaya, Y
    Nakaya, T
    Park, MS
    Cros, J
    Imanishi, J
    Palese, P
    García-Sastre, A
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (17) : 9366 - 9375
  • [4] Homologous prime-boost with Zika virus envelope protein and poly (I:C) induces robust specific humoral and cellular immune responses
    Amaral, Marcelo Pires
    Apostolico, Juliana de Souza
    Tomita, Nadia
    Coirada, Fernanda Caroline
    Santos Lunardelli, Victoria Alves
    Fernandes, Edgar Ruz
    Santos Souza, Higo Fernando
    Astray, Renato Mancini
    Boscardin, Silvia Beatriz
    Rosa, Daniela Santoro
    [J]. VACCINE, 2020, 38 (20) : 3653 - 3664
  • [5] Dynamics of the Humoral Immune Response to a Prime-Boost Ebola Vaccine: Quantification and Sources of Variation
    Pasin, Chloe
    Balelli, Irene
    Van Effelterre, Thierry
    Bockstal, Viki
    Solforosl, Laura
    Prague, Melanie
    Douoguih, Macaya
    Thiebaut, Rodolphe
    [J]. JOURNAL OF VIROLOGY, 2019, 93 (18)
  • [6] Significant Protection against High-Dose Simian Immunodeficiency Virus Challenge Conferred by a New Prime-Boost Vaccine Regimen
    Schell, John B.
    Rose, Nina F.
    Bahl, Kapil
    Diller, Kathryn
    Buonocore, Linda
    Hunter, Meredith
    Marx, Preston A.
    Gambhira, Ratish
    Tang, Haili
    Montefiori, David C.
    Johnson, Welkin E.
    Rose, John K.
    [J]. JOURNAL OF VIROLOGY, 2011, 85 (12) : 5764 - 5772
  • [7] Susceptibility to Simian Immunodeficiency Virus Ex Vivo Predicts Outcome of a Prime-Boost Vaccine After SIVmac239 Challenge
    Ochieng, Washingtone
    Sauermann, Ulrike
    Schulte, Reiner
    Suh, You-Suk
    Kim, Kwang Soon
    Sung, Young C.
    Hunsmann, Gerhard
    Stahl-Hennig, Christiane
    Sopper, Sieghart
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 52 (02) : 162 - 169
  • [8] Prime-boost immunization for high-level mucosal cellular immune responses
    Ramsay, A
    Estcourt, M
    Ramshaw, I
    Boyle, D
    Ranasinghe, C
    [J]. FASEB JOURNAL, 2002, 16 (04): : A308 - A308
  • [9] Strong cellular and humoral anti-HIV Env immune responses induced by a heterologous rhabdoviral prime-boost approach
    Tan, GS
    McKenna, PM
    Koser, ML
    McLinden, R
    Kim, JH
    McGettigan, JP
    Schnell, MJ
    [J]. VIROLOGY, 2005, 331 (01) : 82 - 93
  • [10] Focus and breadth of cellular immune responses elicited by a heterologous insert prime-boost vaccine regimen in rhesus monkeys
    Kaufman, David R.
    Li, Fusheng
    Cruz, Ashley N.
    Self, Steven G.
    Barouch, Dan H.
    [J]. VACCINE, 2012, 30 (03) : 506 - 509